11
TITLE: MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer
AUTHORS: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz Cabrero; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; Joo Hyuk Sohn; Keun Seok Lee; Shah Jalal Sarker; Carike Coetzee; Kelly Mousa; Javier Cortes Castan; ...More
PUBLISHED: 2018, SOURCE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 78, ISSUE: 4
INDEXED IN: WOS
Page 2 of 2. Total results: 11.